BioMonde has manufactured and supplied Larval Therapy products in Europe since 1994 and is now introducing its BioBag for patient use in the United States.
The vastly increasing levels of diabetes combined with an aging population in the USA means that the number of wounds which are unable to heal naturally is increasing significantly.
BioBag is said to provide all the benefits of biosurgery in an easy-to-use contained dressing and its ease of application, rapid debridement and low cost make it a promising solution for non-healing wounds.
Already have an account? Log In
Recommended
Most Popular
Latest Magazine
Features
Nonwovens News talks to Murat Dogru about the upcoming OUTLOOK conference
New line concepts and digital tools are helping nonwovens producers boost output, cut waste and ease labour pressures
New research is exploring the benefits of using PCM impregnated nonwovens for use in composite reinforcements for the construction sector
News
Lenzing to prioritise nonwovens as fibre business reshaped
Turkish yarn manufacturer to enter nonwovens market
Shaping the future of filtration at Filtrex
Other publications from MCL News & Media
